18/11/2024 - Press release
The p95HER2 protein is found expressed in one third of HER2+ tumors, which represent 4% of all tumors. Led by VHIO investigators, CAR T cells targeting p95HER2 have been engineered to secrete the TECH2Me bispecific antibody. Both therapies specifically and independently recognize tumor cells. In addition, the TECH2Me bispecific antibody activates immune cells within the tumor microenvironment. This dual mechanism of action has demonstrated safety and achieved complete and durable antitumor responses in patient-derived models of HER2+ p95HER2-expressing solid tumors. Published in Nature Communications, results of this VHIO-led study have provided the rationale for the application of a phase 1 first-in-human clinical trial, currently in the approval process, to assess this novel therapeutic strategy in patients with HER2-driven solid tumors.
14/11/2024 - Press release
This is a body created to advise the government in this field. Dr. Albert Goday, emeritus section head of the Endocrinology and Nutrition Department at Hospital del Mar, researcher at its research institute, and associate professor of Medicine at UPF, has been appointed president of the Advisory Council on Diabetes in Catalonia. This council's role is to provide guidance to the government on diabetes, and it includes endocrinologists, family doctors, nurses, as well as patients and representatives from patient associations.
13/11/2024 - Press release
The "la Caixa" Foundation has selected 29 new high-impact, socially relevant biomedical research projects. One of these projects, led by the Center for Genomic Regulation, includes participation by Dr. Toni Celià-Terrassa, coordinator of the Cancer Stem Cells and Metastasis Dynamics Research Group at the Hospital del Mar Research Institute.
13/11/2024 - Press release
Conversely, women tolerate it better than men, according to a multicenter study led by Hospital del Mar and its research institute, published in the Journal of Cardiothoracic and Vascular Anesthesia. The study analyzed the outcomes of more than 200 people who underwent a thoracotomy, a type of open surgery that requires separating the ribs to reach the lungs. The differences between men and women are not due to physiological or genetic factors but to a worse initial situation for women regarding their quality of life prior to surgery. The researchers highlight the need to consider this and introduce the idea of addressing psychological components before surgery as part of a personalized approach to pain management.
Més informació "They demonstrate that women suffer more chronic postoperative pain than men"
12/11/2024 - Press release
Dr. Monllau is Professor of Traumatology and Orthopedic Surgery, and Dr. Castells has held the Chair of Preventive Medicine and Public Health since September 12. Both at the Department of Medicine and Health Sciences of the UPF. Dr. Joan Carles Monllau, head of the Orthopedic Surgery and Traumatology Service of the Hospital del Mar and researcher of the Group in cellular research in inflammation and cartilage of the Hospital del Mar Research Institute. Dr. Castells is head of service emeritus of the Epidemiology and Evaluation Service of the Hospital del Mar and investigator of the Epidemiology and Evaluation Research Group of the Hospital del Mar Research Institute.
11/11/2024 - General information
This first episode features Philippe Mortier, researcher from the Health Services Research Group at the Hospital del Mar Research Institute, who, together with Mafalda Dias from (CRG), will explain how they use artificial intelligence tools in their research. Over the upcoming Thursdays in November, the three episodes of the first season of 'Science With a View' will be released, a new podcast from the PRBB communication department in collaboration with Chris George, proposal developer at the Hospital del Mar Research Institute, who hosts this new series. The new program invites two experts from the various PRBB centers to discuss a common theme in their research. It also explores a cross-cutting theme on the scientific career, allowing us to hear opinions from our community in the 'the views of the PRBB' section.
08/11/2024 - Press release
This project is a study on the characterization of genomic complexity in patients with chronic lymphocytic leukemia treated with targeted therapies. Joanna Kamaso, a predoctoral researcher at the Hospital del Mar Research Institute, has received one of the 10 grants awarded by the Fundación Española de Hematología y Hemoterapia (FEHH) for research projects at state institutions. The grant award ceremony took place during the 66th Congress of the Sociedad Española de Hematología y Hemoterapia , held in Palma de Mallorca from October 26 to 28.
06/11/2024 - Press release
This study will be conducted in collaboration with the Josep Carreras Leukemia Research Institute, and researchers from Finland, the Netherlands, and the United Kingdom will participate. The goal is to develop and validate protocols and systems for generating laboratory-derived stem cells to regenerate patients' blood. The European Research Council, which provides these grants, is the leading funding organization for advanced and excellent research on the continent. It is an organization created by the European Union.
29/10/2024 - Press release
They have received three of the 61 grants awarded by SEOM as part of its annual congress held in Madrid. The Sociedad Española de Oncología Médica has awarded 61 grants to medical oncologists, three of them to professionals from Hospital del Mar and its research institute. This is the highest number of grants in its history, with a total allocation of nearly 1.3 million euros. The awards were presented at the society's congress, held from October 15 to 18 in Madrid.
18/10/2024 - Press release
The City Council of Caldes de Montbui and the Hospital del Mar Research Institute are collaborating on a new study that will analyze the effects of thermal water on breast cancer patients. For this reason, they are calling for candidates to be part of the study. The Diputació de Barcelona and the Associació Balneària de Catalunya are also collaborating on the trial. Those who meet the requirements to participate in the study can already submit their application at www.caldesdemontbui.cat/estudicancermama. Candidate selection is expected to begin in early 2025.
Més informació "New Study to Analyze the Effects of Thermal Water on Breast Cancer Patients"
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
